➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Boehringer Ingelheim
McKesson
Moodys
Mallinckrodt

Last Updated: January 18, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Chlorogenic Acid

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Chlorogenic Acid?

Chlorogenic Acid is an investigational drug.

There have been 8 clinical trials for Chlorogenic Acid. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2020.

The most common disease conditions in clinical trials are Neoplasms, Glucose Intolerance, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd, Beijing Cancer Hospital, and Stefan Fischli.

There are seven hundred and sixty-four US patents protecting this investigational drug and six international patents.

Recent Clinical Trials for Chlorogenic Acid
TitleSponsorPhase
Cynara Scolymus Extract for Treatment of Diabetes Mellitus Type 2Stefan FischliPhase 3
Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM PatientsSichuan J.Z. Bio-chemical Science and Technology Development Co., LtdPhase 2/Phase 3
Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung CancerCancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 1/Phase 2

See all Chlorogenic Acid clinical trials

Clinical Trial Summary for Chlorogenic Acid

Top disease conditions for Chlorogenic Acid
Top clinical trial sponsors for Chlorogenic Acid

See all Chlorogenic Acid clinical trials

US Patents for Chlorogenic Acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Chlorogenic Acid   Start Trial Granulation of a stevia sweetener PureCircle Sdn Bhd (Kuala Lumpur, MY)   Start Trial
Chlorogenic Acid   Start Trial Hair dyeing process using at least one ortho-diphenol and one organic salt of titanium and of a carboxylic acid L'OREAL (Paris, FR)   Start Trial
Chlorogenic Acid   Start Trial Methods for improving muscle and heart function BioVentures, LLC (Little Rock, AR)   Start Trial
Chlorogenic Acid   Start Trial Using DNA methyltransferase inhibitors to treat calcific aorta valve disease Mayo Foundation for Medical Education and Research (Rochester, MN)   Start Trial
Chlorogenic Acid   Start Trial Chlorogenic acid-containing composition, method for manufacturing same, and drink or food item FUJIFILM CORPORATION (Tokyo, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Chlorogenic Acid

Drugname Country Document Number Estimated Expiration Related US Patent
Chlorogenic Acid Brazil BR112012011382 2029-11-12   Start Trial
Chlorogenic Acid Canada CA2780561 2029-11-12   Start Trial
Chlorogenic Acid European Patent Office EP2498625 2029-11-12   Start Trial
Chlorogenic Acid European Patent Office EP3461342 2029-11-12   Start Trial
Chlorogenic Acid Spain ES2707280 2029-11-12   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Boehringer Ingelheim
McKesson
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.